Twist Bioscience is a synthetic biology company. Co. has developed multiple products derived from synthetic DNA and its versatile DNA synthesis technology. Co.'s offering consists of two primary product lines, synthetic biology tools and next generation sequencing tools, that address different needs of its customers across a variety of applications, such as synthetic genes, Oligonucleotide, SARS-CoV-2 tools and DNA libraries. Co. has introduced an immunoglobulin G protein offering for its customers focused on drug discovery and development. Utilizing its DNA synthesis platform, Co. has launched a product line of synthetic viral controls in response to the rapid spread of COVID-19.
TWST — Key Stats (updated Friday, September 23, 10:35 AM)